When was 10 mg ever apart of the trial? It's not on clinical trials.gov. Also, it says nothing about switching from from 30 to 50 mg. However, read the below quote from missing in the aaic 2016 pr:
“By utilizing an adaptive design in our current ANAVEX 2-73 Phase 2a study, the treatment was finely adapted to the patient’s response, sparing patients from unnecessary side effects and safeguarding patients’ well-being, as evidenced by a high retention rate in this maximum tolerated dose (MTD) study,” said Christopher U. Missling...
Isn't the above quote confirming individual optimized doses to be given to patients, when missling states "...the treatment was finely adapted to the patient’s response..."
???
News 
Market Data 
Discover 
AI
